Publication Name	World Journal of Gastroenterology
Manuscript ID	7108
Country	United Kingdom

Received	2013-11-05 10:15
Peer-Review Started	2013-11-05 15:32
To Make the First Decision	2013-12-04 09:16
Return for Revision	2013-12-05 19:37
Revised	2013-12-27 01:17
Second Decision	2014-03-13 13:55
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-03-13 16:40
Articles in Press	2014-05-23 11:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-06-30 09:45
Publish the Manuscript Online	2014-07-26 13:36

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Meta-Analysis
Article Title	Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus
Manuscript Source	Invited Manuscript
All Author List	Piers Gatenby, Christine Caygill, Christine Wall, Santanu Bhatacharjee, James Ramus, Anthony Watson and Marc Winslet
Funding Agency and Grant Number	Funding Agency Grant Number Barrett’s Oesophagus Campaign Wexham Gastrointestinal Trust Childwick Trust RL St J Harmsworth Memorial Research Fund David and Frederick Barclay Foundation
Corresponding Author	Piers Gatenby, MD, Division of Surgery and Interventional Science, UCL, Royal Free Campus, Pond Street, London, NW32QG, United Kingdom. p.gatenby@ucl.ac.uk
Key Words	Barrett esophagus; Esophageal neoplasms; Forecasting; Meta-analysis; Cohort studies
Core Tip	The mean life expectancy for patients at diagnosis of Barrett’s esophagus is 22 years. Based on current estimates for high-grade dysplasia and adenocarcinoma incidence, the lifetime risk of requiring an intervention for high-grade dysplasia or adenocarcinoma development based on data from recent meta-analyses is 1 in 5 to 1 in 6 and based on data from recent population-based studies is between 1 in 8 and 1 in 20.
Publish Date	2014-07-26 13:36
Citation	Gatenby P, Caygill C, Wall C, Bhatacharjee S, Ramus J, Watson A, Winslet M. Lifetime risk of esophageal adenocarcinoma in patients with Barrett’s esophagus. World J Gastroenterol 2014; 20(28): 9611-9617
URL	http://www.wjgnet.com/1007-9327/full/v20/i28/9611.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i28.9611

Full Article (PDF)	WJG-20-9611.pdf
Full Article (Word)	WJG-20-9611.doc
Manuscript File	7108-Review.docx
Answering Reviewers	7108-Answering reviewers.pdf
Copyright License Agreement	7108-Copyright assignment.pdf
Peer-review Report	7108-Peer reviewer(s).pdf
Scientific Editor Work List	7108-Scientific editor work list.doc